相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
T. W. Mahungu et al.
HIV MEDICINE (2009)
Associations between CYP2B6 Polymorphisms and Pharmacokinetics after a Single Dose of Nevirapine or Efavirenz in African Americans
David W. Haas et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C→T) with reduced concentrations of unboosted atazanavir
Marco Siccardi et al.
CLINICAL INFECTIOUS DISEASES (2008)
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
Christoph Wyen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1l2 and their association with CYP3A4 expression
Jatinder Lamba et al.
DRUG METABOLISM AND DISPOSITION (2008)
Comparison of the TaqMan and LightCycler systems in evaluation of CYP2B6 516G>T polymorphism
Soranun Chantarangsu et al.
MOLECULAR AND CELLULAR PROBES (2007)
Genetic variability of CYP2B6 polymorphisms in four southern Chinese populations
Bing-Ying Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2007)
Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
S. R. Penzak et al.
HIV MEDICINE (2007)
Impact of nevirapine (NVP) plasma concentration on selection of resistant virus in mothers who received single-dose NVP to prevent perinatal human immunodeficiency virus type 1 transmission and persistence of resistant virus in their infected children
Marie-Laure Chaix et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Response to antiretroviral therapy after a single, peripartum dose of nevirapine
Shahin Lockman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Pharmacogenetics of long-term responses to antiretroviral regimens containing efavirenz and/or nelfinavir:: An adult AIDS clinical trials group study
DW Haas et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
A note on exact tests of Hardy-Weinberg equilibrium
JE Wigginton et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Quality assurance program for clinical measurement of antiretrovirals: AIDS Clinical Trials Group proficiency testing program for pediatric and adult pharmacology laboratories
DT Holland et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy
G Jourdain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
M Lallemant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Pharmacokinetics of antiretrovirals in pregnant women
M Mirochnick et al.
CLINICAL PHARMACOKINETICS (2004)
Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography
JAH Droste et al.
THERAPEUTIC DRUG MONITORING (2003)
Functional characterization of cytochrome P4502B6 allelic variants
H Jinno et al.
DRUG METABOLISM AND DISPOSITION (2003)
Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response
ZL Brumme et al.
AIDS (2003)
Role of polymorphic human CYP2B6 in cyclophosphamide bioactivation
HJ Xie et al.
PHARMACOGENOMICS JOURNAL (2003)
Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture
E Störmer et al.
PHARMACEUTICAL RESEARCH (2002)
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
J Fellay et al.
LANCET (2002)
Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver
T Lang et al.
PHARMACOGENETICS (2001)